Refine identification of the clinical, imaging, biomarker and genetic variables that predict risk of the primary adverse clinical outcomes in HCM.
|Effective start/end date||5/1/21 → 4/30/22|
- MedStar Health Research Institute (5002425009)
- University of Virginia (5002425009)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.